The molecular classification of the clinical manifestations of Crohn's disease.
By T. Ahmad, A. Armuzzi, M. Bunce, K. Mulcahy-Hawes, S. Marshall, T. Orchard, J. Crawshaw, O. Large, A. D. De Silva, J. Cook and 4 more. Gastroenterology, 2002
659 citations recorded by the source corpus.
Subfields: Epidemiology, Genetics, Rheumatology
View Paper: https://www.semanticscholar.org/paper/b65a7c6d4929e9a1d9148920e7c971d8f48a96e5
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Genetics
Citations in the corpus
- Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum (2007, background): “Differences in the genetic susceptibility (Ahmad et al., 2002) and adaptive immune responses to the enteric microflora (Arnott et al., 2004; Targan et al., 2005) of patients with Crohn’s disease involving the ileum, compared to those with CCD, suggest the composition and spatial distribution of the…”
- New IBD genetics: common pathways with other diseases (2011, background): “In Crohn’s disease, NOD2 is associated with a severe stricturing/penetrating ileal disease phenotype.(42) In ulcerative colitis, the HLA DRB1*0103 is associated with extensive and severe disease.”
- Defining the Role of the MHC in Autoimmunity: A Review and Pooled Analysis (2008, neutral): “Finally, HLA-DRB3*0301 was also identified in CD [67,73]; however; this locus has been evaluated in only a few studies.”
- The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. (2009, background): “However, existence of many unaffected individuals homozygous for NOD2/CARD15 mutations emphasizes the importance of environmental influences and genetic interactions (epistasis) with modifier genes in manifestation of clinical disease (45).”